299 Advances in Biopharmaceutics: Cell Line and Process Development

Tuesday, November 18, 2014: 12:30 PM
206 (Hilton Atlanta)
Description:
This session will focus on recent advances in technology, platform, methodology or process developed in biopharmaceutical related area, including academia and industry. It includes but not limited to process, cell line, media optimization; scale up/down, new instruments; case studies etc.

Sponsor:
Pharmaceuticals
Co-Sponsor(s):
Pharmaceutical Discovery, Development and Manufacturing Forum (26)

Chair:
Jianlin (Jim) Xu
Email: jianlin.xu@bms.com

Co-chairs:
Ravishankar Vadali
Email: r_vadali@yahoo.com

Jack Chung-Jr Huang
Email: chuangjr@amgen.com


12:30 PM
Introductory Remarks

12:40 PM
(299b) A Novel and Universal Method for High Mannose Fc Glycan Modulation in Recombinant Therapeutic Antibodies
Jack Chung-Jr Huang, Henry Lin and Jerry Yang

1:05 PM
(299c) Towards Controlling the Glycoform: Bridging the Gap from the Extracellular Environment to Antibody Glycosylation
Philip M Jedrzejewski, Ioscani Jimenez del Val, Antony Constantinou, Anne Dell, Stuart Haslam, Karen M. Polizzi and Cleo Kontoravdi

1:30 PM
Break

1:45 PM
(299a) Optimization of a Novel CHO Cell Bank Production Method
Angela Meier

2:10 PM
(299e) Developing a High Titer Defined Medium and Feed for E. coli Fermentation Systems
Mark Berge, Shushil Machhi, Jaclyn Brennan and Varnika Roy

2:35 PM
(299f) Directional Oscillating Shear in Conventional and Novel Culture Dishes
Jonathan Jones, Amlan Chakraborty, M. Keith Sharp and R. Eric Berson
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division
<< Previous Session | Next Session >>